Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001193125-26-223961

Chief Financial Officer sold 1,448 shares at $18.36 ($26,585)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Lucera Erick · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-05-13 Sale : show line 1 in the form 10b5-1 −1,448 $18.36 $26,585 123,925 D
Open-market sales · 1,448 sh · avg $18.36 · $26,585
Loading xslF345X06/ownership.xml…